ClinicalTrials.govpublic full text
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
platinum-sensitive relapsed epithelial ovarian cancer, platinum-sensitive relapsed fallopian tube cancer, platinum-sensitive relapsed primary peritoneal cancer, ovarian cancer, fallopian tube cancer, primary peritoneal cancer, platinum-sensitive relapsed, torvutatug samrotecan, azd5335, bevacizumab, maintenance treatment, folate receptor alpha
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 904991
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.